GleamWall
中文EN

ATPC Agape ATP Corp

Services-Health Services · Nasdaq · SEC CIK 1713210 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-47.0%
TTM net income YoY76.2%
TTM EPS YoY98.5%
Revenue 3-yr CAGR-18.0%
Net income 3-yr CAGR—

Margins

Gross margin52.1%
Operating margin-372.9%
Net margin-82.9%
FCF margin—
EBITDA margin-372.4%

Returns

ROE-2.9%
ROA-2.6%
ROIC (approx.)-10.4%
Asset turnover0.03x

Leverage & solvency

Liabilities / assets13.2%
Debt / equity0.00x
Current ratio7.59x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.05x
Accruals ratio0.1%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$1.52M$1.32M$1.43M$1.86M$1.02M
Cost of revenue$685,992$563,599$494,516$666,042$297,333
Gross profit$838,270$759,148$936,572$1.19M$719,629
SG&A expense$3.78M$3.13M$2.37M$1.96M$1.75M
Operating income-$3.26M-$2.57M-$2.15M-$1.53M-$1.86M
Pretax income-$2.31M-$2.48M-$2.11M-$1.67M-$2.39M
Income tax$2,285$4,934$3,575-$4,055$137,067
Net income-$2.28M-$2.47M-$2.10M-$1.69M-$2.52M
EBITDA-$3.24M-$2.52M-$2.08M-$1.46M-$1.78M
EPS (basic)-2.85-31.74-0.55-0.02-0.01
EPS (diluted)-2.85-31.74-0.55-0.02-0.01
Weighted avg. shares (diluted)801,08177,8393.79M87.82M376.22M
Banking
Deposits$89,651$2.03M$4.82M$1.43M$554,864
Balance sheet
Cash & equivalents$89,651$1.99M$4.83M$1.44M$2.60M
Receivables$4,023$53,651$55,458$2,826—
Inventory$26,148$46,347$47,907$46,277$375,535
Current assets$24.29M$2.78M$5.19M$2.03M$3.91M
PP&E, net$5,140$31,463$77,858$142,149$215,799
Intangibles$1$13,082$17,458$24,044$3,660
Total assets$24.59M$3.24M$5.74M$2.79M$4.72M
Current liabilities$2.05M$1.12M$1.07M$1.23M$1.31M
Total liabilities$2.17M$1.31M$1.36M$1.23M$1.41M
Shareholders' equity$22.46M$1.93M$4.37M$1.54M$3.31M
Shares outstanding1.00M79,7813.86M75.45M290.46M
Cash flow statement
Operating cash flow-$2.41M-$2.73M-$2.00M-$811,683-$845,842
Capital expenditure————$3,959
Free cash flow————-$849,801
Investing cash flow-$23.00M-$50,050-$17,251-$32,119-$3,959
Financing cash flow$23.50M-$11,856$5.40M-$234,466-$19,061
Depreciation & amortization$20,189$52,570$70,337$71,754$75,797

Free plan shows the latest 5 periods; Pro shows all 10 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-19 06:28.